Post-cardiotomy venovenous extracorporeal membrane oxygenation without heparinization.


Journal

General thoracic and cardiovascular surgery
ISSN: 1863-6713
Titre abrégé: Gen Thorac Cardiovasc Surg
Pays: Japan
ID NLM: 101303952

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 25 05 2018
accepted: 11 08 2018
pubmed: 19 8 2018
medline: 17 1 2020
entrez: 19 8 2018
Statut: ppublish

Résumé

We present the cases of eight patients (mean age 75 years; EuroSCORE II 17.0 ± 22.0) who underwent post-cardiotomy venovenous extracorporeal membrane oxygenation (ECMO) without heparinization due to serious bleeding. Three liver cirrhosis, two chronic hemodialysis, three redo sternotomy, and two urgent surgery cases were included. Respiratory ECMO Survival Prediction score was - 5.1 ± 4.2 (estimated survival rate: approximately 30%). Mean ECMO duration was 14 days with 9 circuit exchanges. Five patients were weaned from ECMO and three were discharged alive at 90 days (survival 37.5%). There was a case of pump-head thrombosis requiring urgent circuit exchange. All experienced bleeding complications without clinically apparent pulmonary thromboembolism. Disseminated Intravascular Coagulation scores (Pre 1.3 ± 0.8 vs. Post 3.8 ± 1.7; p < 0.05) significantly increased (N = 6). Post-cardiotomy ECMO without heparinization facilitated patient rescue at a reasonable survival rate. However, bleeding complications were still observed. More sophisticated management protocols are warranted.

Identifiants

pubmed: 30120673
doi: 10.1007/s11748-018-0990-2
pii: 10.1007/s11748-018-0990-2
doi:

Substances chimiques

Anticoagulants 0
Heparin 9005-49-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

982-986

Références

Eur J Cardiothorac Surg. 1999 Apr;15(4):508-14
pubmed: 10371130
Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5
pubmed: 22378855
Semin Cardiothorac Vasc Anesth. 2009 Sep;13(3):154-75
pubmed: 19767408
Am J Respir Crit Care Med. 2014 Jun 1;189(11):1374-82
pubmed: 24693864
J Artif Organs. 2017 Dec;20(4):377-380
pubmed: 28986731
Am Rev Respir Dis. 1988 Sep;138(3):720-3
pubmed: 3202424
Gen Thorac Cardiovasc Surg. 2011 Sep;59(9):597-8
pubmed: 22231785
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Gen Thorac Cardiovasc Surg. 2013 Jul;61(7):402-8
pubmed: 23436039
Transfus Med Rev. 2015 Apr;29(2):90-101
pubmed: 25595476
Crit Care Med. 1998 Nov;26(11):1793-800
pubmed: 9824069
J Cardiothorac Vasc Anesth. 2017 Jun;31(3):869-875
pubmed: 28082026
J Thorac Dis. 2017 Dec;9(12):5017-5029
pubmed: 29312706
Intensive Care Med. 2016 May;42(5):712-724
pubmed: 27007108
Thromb Res. 2012 Apr;129(4):e119-25
pubmed: 22138415

Auteurs

Masami Takagaki (M)

Department of Cardiovascular Surgery, Showa University Koto Toyosu Hospital, 5-1-38 Toyosu, Koto-ku, Tokyo, 135-8577, Japan.

Hiroki Yamaguchi (H)

Department of Cardiovascular Surgery, Showa University Koto Toyosu Hospital, 5-1-38 Toyosu, Koto-ku, Tokyo, 135-8577, Japan. hiroyamaguchiskt@gmail.com.

Naoko Ikeda (N)

Department of Cardiology, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Kaori Takeda (K)

Department of Nursing, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Fumihito Kasai (F)

Department of Rehabilitation, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Kiyotaka Yahagi (K)

Department of Clinical Engineering, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Shunji Kanzaki (S)

Department of Clinical Engineering, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Shinichi Mitsuyama (S)

Department of Cardiovascular Surgery, Showa University Koto Toyosu Hospital, 5-1-38 Toyosu, Koto-ku, Tokyo, 135-8577, Japan.

Tasuku Kadowaki (T)

Department of Cardiovascular Surgery, Showa University Koto Toyosu Hospital, 5-1-38 Toyosu, Koto-ku, Tokyo, 135-8577, Japan.

Toru Kotani (T)

Department of Anesthesiology, Showa University Hospital, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH